ArticleCancer biology & therapy2022

Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy.

Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.